Emany Sravan Kumar 4
4 · Beam Therapeutics Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Emany Sravan Kumar
Chief Financial Officer
Transactions
- Award
Common Stock
2024-12-31+80,000→ 80,000 total - Award
Stock Option (Right to Buy)
2024-12-31+160,000→ 160,000 totalExercise: $24.80Exp: 2034-12-31→ Common Stock (160,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in four substantially equal installments on each of the first four anniversaries of December 31, 2024, subject to the Reporting Person's continued service with BEAM through each vesting date.
- [F2]This stock option vests as to 25% on the first anniversary of the vesting commencement date, December 31, 2024, and at a rate of 2.78% each month thereafter until the option is fully vested.